 |
Full Conference Video Recordings
Available on USB Flash Drive
This package features video recordings of all sessions recorded exactly as they happened at the Massachusetts General Hospital Psychiatry Academy "Psychedelics and Psychedelic Medicine" Conference, held November 3-4, 2023.
Includes video files of every session. This package allows you to review presentations and is a lasting valuable resource.
|
INCLUDES ALL OF THE PRESENTATIONS FROM THE CONFERENCE:
| Friday, November 3, 2023 |
|
| Welcome and Introduction |
Franklin King, MD |
| A Brief History of Psychedelics |
Franklin King, MD |
| Pharmacology |
Franklin King, MD |
| Keynote: Psychedelic-Assisted Therapy: a 21st Century Approach to Mental Health? |
Rick Doblin, MD |
| Question & Answer |
Franklin King, MD; Rick Doblin, MD |
| Challenges in Trial Design for Psychedelic-Assisted Therapies |
Jacob Aday, PhD |
| Risks and Harms in Psychedelics and Psychedelic-Assisted Therapies |
Alden Doerner Rinaldi, MD |
| Psychedelic Therapies: Evidence-b(i)ased Medicine |
Eduardo Schenberg, PhD |
| Panel Discussion |
Franklin King, MD; Jacob Aday, PhD; Alden Doerner Rinaldi, MD; Eduardo Schenberg, PhD. |
| Psychedelic-Assisted Psychotherapy |
Elizabeth Call, PhD |
| What’s Therapy Got to Do With It? |
Michael Alpert, MD |
| Panel Discussion |
Franklin King, MD; Elizabeth Call, PhD, Michael Alpert, MD |
| Ketamine and Esketamine for Major Depression |
Cristina Cusin, MD |
| Ketamine-Assisted Psychotherapy – Inpatient Treatment of the Future? |
Fernando Espi Forcen, MD |
| Panel Discussion |
Franklin King, MD; Cristina Cusin, MD; Fernando Espi Forcen, MD |
| Using Cognitive Neuroscience To Advance Treatment with Psychedelics |
Alfred Kaye, MD, PhD |
| Neurobiology of Plant Medicine |
Stephen Haggarty, MD |
| The Role of Cognitive Flexibility in Psychedelic Experiences |
Frederick Barrett, PhD |
| Panel Discussion |
Alfred Kaye, MD, PhD.; Stephen Haggarty, PhD; Frederick Barrett, PhD |
| Saturday, November 4, 2023 |
|
| Welcome & Introduction |
Roxanne Sholevar, MD; Zachary Sager, MD; Yvan Beaussant, MD |
| Psychedelic-Assisted Therapies in End-of-Life Care |
Roxanne Sholevar, MD; Zachary Sager, MD; Yvan Beaussant, MD |
| Panel Discussion |
Franklin King, MD; Roxanne Sholevar, MD; Yvan Beaussant, MD; Zachary Sager, MD |
| Psilocybin Treatment For Depression |
Kelley O’Donnell, MD, PhD |
| Psychedelics and Addictions |
Brian Barnett, MD |
| Psychedelics for autism spectrum disorders? Promises and Perils |
Alicia Danforth, PhD |
| Amplifying PTSD Treatments with MDMA |
Anne Wagner, PhD |
| Panel Discussion |
Franklin King, MD; Brian Barnett, MD; Alicia Danforth, PhD; Anne Wagner, PhD |
| Challenging Structural Racism in Psychedelic Research |
Darron Smith, PhD |
| Education and Training in Psychedelic-Assisted Therapies |
Janis Phelps, PhD |
| Panel Discussion |
Franklin King, MD; Darron Smith, PhD; Janis Phelps, PhD |
| Psilocybin-Assisted Therapy for Irritable Bowel Syndrome |
Erin Mauney, MD |
| Novel Research Approaches for Psychedelics and Pain Disorders |
Vitaly Napadow, PhD |
| Psychedelics and Spirituality |
Michael Ferguson, PhD |
| Panel Discussion |
Franklin King, MD; Erin Mauney, MD; Vitaly Napadow, PhD |
|
